Literature DB >> 20927527

Assessment of tissue perfusion by contrast-enhanced ultrasound.

Emilio Quaia1.   

Abstract

Contrast-enhanced ultrasound (CEUS) with microbubble contrast agents is a new imaging technique for quantifying tissue perfusion. CEUS presents several advantages over other imaging techniques in assessing tissue perfusion, including the use of microbubbles as blood-pool agents, portability, availability and absence of exposure to radiation or nuclear tracers. Dedicated software packages are necessary to quantify the echo-signal intensity and allow the calculation of the degree of tissue contrast enhancement based on the accurate distinction between microbubble backscatter signals and native tissue background. The measurement of organ transit time after microbubble injection and the analysis of tissue reperfusion kinetics represent the two fundamental methods for the assessment of tissue perfusion by CEUS. Transit time measurement has been shown to be feasible and has started to become accepted as a clinical tool, especially in the liver. The loudness of audio signals from spectral Doppler analysis is used to generate time-intensity curves to follow the wash-in and wash-out of the microbubble bolus. Tissue perfusion may be quantified also by analysing the replenishment kinetics of the volume of microbubbles after their destruction in the imaged slice. This allows to obtain semiquantitative parameters related to local tissue perfusion, especially in the heart, brain, and kidneys.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20927527     DOI: 10.1007/s00330-010-1965-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  89 in total

1.  Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging.

Authors:  J Hancock; H Dittrich; D E Jewitt; M J Monaghan
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

2.  Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Thomas E Yankeelov; Kenneth J Niermann; Jessica Huamani; Dong W Kim; Christopher C Quarles; Arthur C Fleischer; Dennis E Hallahan; Ronald R Price; John C Gore
Journal:  J Ultrasound Med       Date:  2006-04       Impact factor: 2.153

3.  Pathologic skeletal muscle perfusion in patients with myositis: detection with quantitative contrast-enhanced US--initial results.

Authors:  Marc-André Weber; Martin Krix; Uta Jappe; Hagen B Huttner; Marius Hartmann; Uta Meyding-Lamadé; Marco Essig; Christoph Fiehn; Hans-Ulrich Kauczor; Stefan Delorme
Journal:  Radiology       Date:  2005-12-21       Impact factor: 11.105

Review 4.  Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography.

Authors:  Roxy Senior; Harald Becher; Mark Monaghan; Luciano Agati; Jose Zamorano; Jean Louis Vanoverschelde; Petros Nihoyannopoulos
Journal:  Eur J Echocardiogr       Date:  2009-03

5.  Blood perfusion of the contralateral testis evaluated with contrast-enhanced ultrasound in rabbits with unilateral testicular torsion.

Authors:  Lin Chen; Wei-Wei Zhan; Zhou-Jun Shen; Wen-Bin Rui; Chen Lv; Man Chen; Jian-Qiao Zhou; Ping Zhou; Mi Zhou; Ying Zhu
Journal:  Asian J Androl       Date:  2009-01-19       Impact factor: 3.285

6.  Parametric perfusion imaging based on low-cost ultrasound platform.

Authors:  Xiaolin Gu; Hui Zhong; Mingxi Wan; Xiaowen Hu; Dan Lv; Liang Shen; Xiaomei Zhang
Journal:  Ultrasound Med Biol       Date:  2010-01       Impact factor: 2.998

7.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

Authors:  K Wei; A R Jayaweera; S Firoozan; A Linka; D M Skyba; S Kaul
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

8.  Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion.

Authors:  Mark A Green; Carla J Mathias; Lynn R Willis; Rajash K Handa; Jeffrey L Lacy; Michael A Miller; Gary D Hutchins
Journal:  Nucl Med Biol       Date:  2007-04       Impact factor: 2.408

9.  Parametric perfusion imaging with contrast-enhanced ultrasound in acute ischemic stroke.

Authors:  Martin Wiesmann; Karsten Meyer; Thomas Albers; Günter Seidel
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914

10.  Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.

Authors:  Joachim Hohmann; Christine Müller; Anja Oldenburg; Jan Skrok; Bernd B Frericks; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  Ultrasound Med Biol       Date:  2009-06-21       Impact factor: 2.998

View more
  30 in total

1.  Evaluating the effects of diclofenac sodium and etodolac on renal hemodynamics with contrast-enhanced ultrasonography: a pilot study.

Authors:  Hiroshi Imamura; Jiro Hata; Ai Iida; Noriaki Manabe; Ken Haruma
Journal:  Eur J Clin Pharmacol       Date:  2012-06-26       Impact factor: 2.953

2.  Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials.

Authors:  Edward Leen; Michalakis Averkiou; Marcel Arditi; Peter Burns; Daniela Bokor; Thomas Gauthier; Yuko Kono; Olivier Lucidarme
Journal:  Eur Radiol       Date:  2012-07       Impact factor: 5.315

3.  Quantification of Microvascular Tortuosity during Tumor Evolution Using Acoustic Angiography.

Authors:  Sarah E Shelton; Yueh Z Lee; Mike Lee; Emmanuel Cherin; F Stuart Foster; Stephen R Aylward; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2015-04-07       Impact factor: 2.998

4.  On the Relationship between Dynamic Contrast-Enhanced Ultrasound Parameters and the Underlying Vascular Architecture Extracted from Acoustic Angiography.

Authors:  Anastasiia Panfilova; Sarah E Shelton; Cristina Caresio; Ruud J G van Sloun; Filippo Molinari; Hessel Wijkstra; Paul A Dayton; Massimo Mischi
Journal:  Ultrasound Med Biol       Date:  2018-11-30       Impact factor: 2.998

5.  CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Authors:  Sila Cocciolillo; Giustino Parruti; Leonardo Marzio
Journal:  World J Hepatol       Date:  2014-07-27

6.  Early assessment of chronic kidney dysfunction using contrast-enhanced ultrasound: a pilot study.

Authors:  Y Dong; W-P Wang; J Cao; P Fan; X Lin
Journal:  Br J Radiol       Date:  2014-07-25       Impact factor: 3.039

7.  Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.

Authors:  Huaijun Wang; Amelie M Lutz; Dimitre Hristov; Lu Tian; Jürgen K Willmann
Journal:  Radiology       Date:  2016-08-04       Impact factor: 11.105

8.  Microvascular perfusion and intramuscular temperature of the calf during cooling.

Authors:  Noelle M Selkow; Carly Day; Zhenqi Liu; Joseph M Hart; Jay Hertel; Susan A Saliba
Journal:  Med Sci Sports Exerc       Date:  2012-05       Impact factor: 5.411

9.  Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.

Authors:  Huaijun Wang; Dimitre Hristov; Jiale Qin; Lu Tian; Jürgen K Willmann
Journal:  Radiology       Date:  2015-05-22       Impact factor: 11.105

10.  Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.

Authors:  Jianhua Zhou; Huiping Zhang; Huaijun Wang; Amelie M Lutz; Ahmed El Kaffas; Lu Tian; Dimitre Hristov; Jürgen K Willmann
Journal:  Angiogenesis       Date:  2017-07-18       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.